The HIV epidemic has triggered a sharp increase in the burden of tuberculosis (TB) in sub-Saharan Africa. An emerging consensus suggests that the conventional strategy for global TB control, based on passive identification of individuals with active pulmonary disease, may not be sufficiently aggressive to address HIV-fuelled TB epidemics. As a result, the World Health Organization has updated recommendations to support wider use of treatment for latent M. tuberculosis infection (TLTBI) and more active screening for TB disease, as two key components of a new strategic approach for control of HIV-associated TB epidemics. Community-randomized studies testing these strategies on a broad population-wide scale, have produced disappointing results thus far. We hypothesize that targeted use of TLTBI and active TB case-finding may prove more effective, and more cost-effective, than non-targeted use. Our overall goal in this project is to use mathematical models of TB and HIV epidemics to examine this hypothesis and evaluate the comparative effectiveness and efficiency of alternative choices in the design and implementation of targeted strategies. Toward this goal our project has three specific aims: (1) To develop a detailed simulation model of TB/HIV co-epidemics and calibrate the model to 9 high burden countries in sub-Saharan Africa. (2) To use this model to identify strategies for effective and cost-effective use of targeted screening for active tuberculosis. (3) To use this model to identify strategies for effective and cost-effective use of targeted TLTBI. Mathematical models can provide a unique approach to consolidate information from available studies to compare the projected effects (and costs) of alternative strategies for targeting and combining screening interventions. The models we propose aim to meet this critical need and supply new tools to inform development and revision of national and international strategies for deploying interventions that can maximize impact and value for money when used singly and in combination. We expect this study to provide essential information for policy makers and researchers seeking to identify key priorities and set targets for tuberculosis control in settings of high HIV prevalence. In addition to providing evidence with immediate relevance to policy, the approach developed in this study will provide a durable template for further analyses, including prospective assessment of other targeted or general TB control strategies; retrospective evaluation of the impact and cost- effectiveness of programs; and monitoring of progress towards key goals for reducing the burdens of TB and HIV in resource limited settings.

Public Health Relevance

The HIV epidemic has triggered a sharp increase in the burden of tuberculosis (TB) in sub-Saharan Africa. An emerging consensus points to a need to revise conventional strategies for TB control in high HIV settings to include wider use of treatment for latent TB infection (preventive therapy) and more active screening for TB disease, but implementation of these strategies on a community-wide basis has thus far yielded disappointing results. This project aims to provide a rigorous, systematic and comprehensive examination of the potential impact and value for money associated with more targeted approaches to preventive therapy and active TB case-finding in 9 countries in sub-Saharan Africa with high TB and HIV burdens.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI112438-03
Application #
8876577
Study Section
AIDS Clinical Studies and Epidemiology Study Section (ACE)
Program Officer
Huebner, Robin E
Project Start
2014-07-01
Project End
2018-06-30
Budget Start
2015-07-01
Budget End
2016-06-30
Support Year
3
Fiscal Year
2015
Total Cost
Indirect Cost
Name
Yale University
Department
Public Health & Prev Medicine
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
Marx, Florian M; Yaesoubi, Reza; Menzies, Nicolas A et al. (2018) Tuberculosis control interventions targeted to previously treated people in a high-incidence setting: a modelling study. Lancet Glob Health 6:e426-e435
Morozova, Olga; Cohen, Ted; Crawford, Forrest W (2018) Risk ratios for contagious outcomes. J R Soc Interface 15:
Zimmer, Christoph; Leuba, Sequoia I; Cohen, Ted et al. (2018) Accurate quantification of uncertainty in epidemic parameter estimates and predictions using stochastic compartmental models. Stat Methods Med Res :962280218805780
Auld, Sara C; Shah, N Sarita; Cohen, Ted et al. (2018) Where is tuberculosis transmission happening? Insights from the literature, new tools to study transmission and implications for the elimination of tuberculosis. Respirology :
Yang, Chongguang; Lu, Liping; Warren, Joshua L et al. (2018) Internal migration and transmission dynamics of tuberculosis in Shanghai, China: an epidemiological, spatial, genomic analysis. Lancet Infect Dis 18:788-795
Menzies, Nicolas A; Soeteman, Djøra I; Pandya, Ankur et al. (2017) Bayesian Methods for Calibrating Health Policy Models: A Tutorial. Pharmacoeconomics 35:613-624
Zimmer, Christoph; Yaesoubi, Reza; Cohen, Ted (2017) A Likelihood Approach for Real-Time Calibration of Stochastic Compartmental Epidemic Models. PLoS Comput Biol 13:e1005257
Yates, Tom A; Khan, Palwasha Y; Knight, Gwenan M et al. (2016) The transmission of Mycobacterium tuberculosis in high burden settings. Lancet Infect Dis 16:227-38
Menzies, Nicolas A; Gomez, Gabriela B; Bozzani, Fiammetta et al. (2016) Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models. Lancet Glob Health 4:e816-e826
Kunkel, Amber; Crawford, Forrest W; Shepherd, James et al. (2016) Benefits of continuous isoniazid preventive therapy may outweigh resistance risks in a declining TB/HIV co-epidemic. AIDS :

Showing the most recent 10 out of 18 publications